On (b)(6) 2016, the physician treated a patient at the great saphenous vein and anterior accessory great saphenous vein using a venaseal device.Ifu was followed.3 veins were treated and all 3 closed.Physician accessed 3 sites - 2 on right and 1 on left.Treated approx.55 cm right gsv.Treated approx.25 cm left gsv.Treated approx.10 cm right accessory vein connected to gsv.It is reported that the day after the procedure the patient began to experience increased redness at treatment site, hot to touch, itchiness and chills.Physician provided nsaids to patient.Additional treatment was then provided - oral steroid, specifically solumedrol (2 courses) and the continued use of benadryl and hydrocortisone cream (at affected areas).On (b)(6) 2016, the patient was still tender and warm to touch but with less redness.Five days later, patient had red itchy hives all over body and a swollen face and eyes.Primary care physician increased oral steroid dosage to 60 mg.On (b)(6) 2016, physician stated the patient had exposure to dermabond without reaction.Patient was responding to oral steroid regimen.Once initial steroid pack was completed, patient's primary physician prescribed a 40 mg treatment of oral steroids.Although symptoms were marginally improved, patient was still experiencing itchiness/redness/areas hot to touch on legs and side.At 3 week follow-up, hives on patient's arms/legs/side/face were reported to be gone.However, pain in the legs was worse.Physician said the patient was doing well on oral steroids and treatment was being tapered off slowly.All blood work came back normal.Additional blood work performed to test for possible drug induced lupus.Results came back negative.
|
Additional information received 11/oct/2016: patient reported to have edema on both legs.Still gets red when standing, itchy and hot.Patient broke out in hives again.Oral steroid (prednisone) dosage was lowered to 40mg from 60mg.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|